Alpha memo: therapeutic hypothermia outcome evidence varies with population or endpoint definition

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Drop or explicitly hedge the IHCA-vs-OHCA sub-signal in the abstract/alpha sentence since neither cited receipt supports it; if retained, reframe as a hypothesized falsifier rather than a finding.
2. Tighten the 'why surprising' paragraph to a single bounded cross-receipt contrast (rewarming-rate confounding vs glucose-variability as a separate in-treatment axis); remove the ungrounded 'overlapping moderators' causal language.
3. Replace 'species' wording with the actual cohort/endpoint contrast.
4. Confirm glucose-variability is framed as a candidate modifier with unknown causal status, not an established driver.

Major issues

• The alpha sentence bundles three heterogeneous sub-signals (rewarming-rate attenuation, glucose variability, IHCA vs OHCA context) without naming the primary boundary clearly; the 'why surprising' framing asserts moderation that the cited receipts do not jointly test.
• IHCA vs OHCA conditioning is asserted in the abstract and one-sentence alpha but is not supported by either receipt bundle entry (Bouwes 2012 and Cueni-Villoz 2011 abstracts do not establish an IHCA/OHCA contrast); this is an overclaim relative to the cited evidence.

Minor issues

• Receipt 2 cites a 2011 study as 'earlier mechanistic context,' but it is contemporaneous clinical observational evidence with a 220-patient cohort; characterize accordingly.
• The 'species (both human but distinct ICU cohorts)' contrast is artifactual — both studies are human clinical cohorts; the real contrast is endpoint family, which is already noted.

Reviewer note

Bounded two-receipt evidence map on therapeutic hypothermia post-cardiac arrest. Receipt 1 (Bouwes 2012) directly supports the rewarming-rate attenuation claim (adjusted OR 1.51, 95% CI 0.64–3.58, abstract confirmed). Receipt 2 (Cueni-Villoz 2011) supports a glucose-variability signal during hypothermia (220-patient prospective observational cohort, abstract confirmed). However, the alpha sentence introduces an IHCA-vs-OHCA conditioning sub-signal that is not grounded in either receipt bundle, constituting mild overclaim. Synthesis is adequate but uneven — the cross-receipt integration is plausible but the framing pushes toward 'overlapping moderators' causal language that the two observational receipts cannot jointly support. Revise to remove the IHCA/OHCA finding language and tighten the contrast to receipt-grounded axes.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis